×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TEVA – teva pharmaceutical industries limited american depositary shares (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TEVA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/14
05:02 pm
teva
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
Low
Report
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
1/13
07:46 pm
teva
Is It Too Late To Reassess Teva (TEVA) After A 55% One Year Rally? [Yahoo! Finance]
Low
Report
Is It Too Late To Reassess Teva (TEVA) After A 55% One Year Rally? [Yahoo! Finance]
1/13
07:07 pm
teva
Public advisory -Teva Octreotide for injectable suspension recalled due to potential drug quality issues [Yahoo! Finance]
Low
Report
Public advisory -Teva Octreotide for injectable suspension recalled due to potential drug quality issues [Yahoo! Finance]
1/11
07:40 pm
teva
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation [Yahoo! Finance]
Low
Report
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation [Yahoo! Finance]
1/11
06:00 pm
teva
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
Low
Report
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
1/11
05:13 pm
teva
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo [Yahoo! Finance]
Low
Report
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo [Yahoo! Finance]
1/11
05:00 pm
teva
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Low
Report
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
1/11
08:22 am
teva
Teva Pharmaceutical Industries Limited's (NYSE:TEVA) high institutional ownership speaks for itself as stock continues to impress, up 3.4% over last week [Yahoo! Finance]
Low
Report
Teva Pharmaceutical Industries Limited's (NYSE:TEVA) high institutional ownership speaks for itself as stock continues to impress, up 3.4% over last week [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/5/2025
07:00 am
TEVA
teva pharmaceutical industries limited american depositary shares
BEAT
Report
9.9%
teva pharmaceutical industries limited american depositary shares
7/30/2025
07:00 am
TEVA
teva pharmaceutical industries limited american depositary shares
BEAT
Report
0.4%
teva pharmaceutical industries limited american depositary shares
5/7/2025
07:00 am
TEVA
teva pharmaceutical industries limited american depositary shares
BEAT
Report
5.3%
teva pharmaceutical industries limited american depositary shares
1/29/2025
07:00 am
TEVA
teva pharmaceutical industries limited american depositary shares
BEAT
Report
-14.1%
teva pharmaceutical industries limited american depositary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/12
06:02 am
teva
Form 8-K TEVA PHARMACEUTICAL INDU For: Jan 11
Medium
Report
Form 8-K TEVA PHARMACEUTICAL INDU For: Jan 11
12/18
04:04 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Dec 16 Filed by: Weiss Amir
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Dec 16 Filed by: Weiss Amir
12/18
04:03 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Dec 16 Filed by: MIGNONE ROBERTO
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Dec 16 Filed by: MIGNONE ROBERTO
12/12
04:17 pm
teva
Form 144 TEVA PHARMACEUTICAL INDU Filed by: BRIDGER MANAGEMENT, LLC
Low
Report
Form 144 TEVA PHARMACEUTICAL INDU Filed by: BRIDGER MANAGEMENT, LLC
12/11
04:31 pm
teva
Form 8-K TEVA PHARMACEUTICAL INDU For: Dec 10
Low
Report
Form 8-K TEVA PHARMACEUTICAL INDU For: Dec 10
12/11
04:09 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Dec 09 Filed by: Daniell Richard
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Dec 09 Filed by: Daniell Richard
12/11
04:07 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Dec 09 Filed by: Sabag Mark
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Dec 09 Filed by: Sabag Mark
12/9
04:03 pm
teva
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Sabag Mark
Medium
Report
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Sabag Mark
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
10/18
Shortage of critical children’s cancer drug causes concerns nationwide [MSNBC.com]
16.9%
8/7 Dow Takes a Sharp Dive as Treasury Yields Tumble [TheStreet.com] 13.9%
2/12 New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion 10.7%
11/7 Form 10-Q TEVA PHARMACEUTICAL INDU For: Sep 30 10.5%
10/16 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was upgraded by analysts at Gabelli from a "hold" rating to a "buy" rating. 10.4%
1/13 Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 38th Annual JP Morgan Healthcare Conference (Transcript) [Seeking Alpha] 9.7%
2/3 Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan 7.7%
9/6 Purdue Pharma in talks to settle DOJ opioid probes - WSJ [Seeking Alpha] 7.2%
6/24 UPDATE 2-Oklahoma judge approves Teva's $85 million opioid settlement [Reuters (UK)] 7.0%
11/26 U.S. prosecutors open criminal probe of opioid makers, distributors [Reuters (UK)] 6.7%
8/7 Dow Takes a Sharp Dive as Treasury Yields Tumble [TheStreet.com] 13.9%
2/12 New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion 10.7%
11/7 Form 10-Q TEVA PHARMACEUTICAL INDU For: Sep 30 10.5%
10/16 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was upgraded by analysts at Gabelli from a "hold" rating to a "buy" rating. 10.4%
1/13 Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 38th Annual JP Morgan Healthcare Conference (Transcript) [Seeking Alpha] 9.7%
2/3 Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan 7.7%
9/6 Purdue Pharma in talks to settle DOJ opioid probes - WSJ [Seeking Alpha] 7.2%
6/24 UPDATE 2-Oklahoma judge approves Teva's $85 million opioid settlement [Reuters (UK)] 7.0%
11/26 U.S. prosecutors open criminal probe of opioid makers, distributors [Reuters (UK)] 6.7%
TOP News Decliners
5/11
U.S. states sue Teva, 19 other drug companies in price-fixing complaint [Reuters (UK)]
-14.7%
5/28 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. -13.8%
3/12 Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®? (fremanezumab) -13.5%
8/6 Earnings Outlook: Teva Pharmaceuticals reports earnings on Wednesday. Here’s what to expect [MarketWatch] -11.2%
3/19 Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide -10.2%
11/25 Form 8-K TEVA PHARMACEUTICAL INDU For: Nov 25 -8.0%
5/30 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. -6.9%
4/21 QuestCap Appoints Douglas Sommerville as President of MedQuest Investment Division [Canadian Business Journal (Canada)] -6.9%
10/7 Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 -6.4%
11/6 Form 4 TEVA PHARMACEUTICAL INDU For: Nov 05 Filed by: McClellan Michael James -6.1%
5/28 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. -13.8%
3/12 Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®? (fremanezumab) -13.5%
8/6 Earnings Outlook: Teva Pharmaceuticals reports earnings on Wednesday. Here’s what to expect [MarketWatch] -11.2%
3/19 Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide -10.2%
11/25 Form 8-K TEVA PHARMACEUTICAL INDU For: Nov 25 -8.0%
5/30 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. -6.9%
4/21 QuestCap Appoints Douglas Sommerville as President of MedQuest Investment Division [Canadian Business Journal (Canada)] -6.9%
10/7 Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 -6.4%
11/6 Form 4 TEVA PHARMACEUTICAL INDU For: Nov 05 Filed by: McClellan Michael James -6.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: